Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Ocuphire Pharma
Ocuphire Pharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Ryzumvi
Phentolamine
2023-09-25
2034-2039
Necrosis
,
Extravasation of diagnostic and therapeutic materials
,
Malignant hypertension
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Phentolamine
obesity
,
healthy volunteers/patients
,
heart failure
,
type 1 diabetes mellitus
,
hypoglycemia
,
chronic obstructive pulmonary disease
,
pulmonary arterial hypertension
,
obstructive lung diseases
,
vasculogenic impotence
,
stem cell transplantation
,
insulin resistance
,
cardiovascular diseases
,
obstructive sleep apnea
,
sleep apnea syndromes
,
menopause
,
erectile dysfunction
,
prostatic neoplasms
,
ocular hypertension
,
glaucoma
,
open-angle glaucoma
,
hypesthesia
,
hypertension
,
pathologic dilatation
,
dilatation
,
mydriasis
,
presbyopia
,
drug-related side effects and adverse reactions
,
ischemic stroke
,
soft tissue injuries
,
acute kidney injury
,
wounds and injuries
,
acute coronary syndrome
,
coronary artery disease
,
night blindness
,
mesopic vision
,
vision disorders
,
vitamin a deficiency
,
vasodilation
,
dental anesthesia
,
local anesthesia
,
vasoconstriction
,
pre-eclampsia
,
multiple myeloma
,
plasma cell neoplasms
,
neoplasm metastasis
,
pregnancy complications
,
eclampsia
,
stroke
,
cerebral hemorrhage
,
pneumonia
,
community-acquired pneumonia
,
intracranial hemorrhages
,
hemorrhage
,
diabetes mellitus
,
inflammation
,
hypotension
,
preoperative period
,
pathologic constriction
,
miosis
APX-3330
macular edema
,
retinal diseases
,
diabetic retinopathy
Demand
neoplasm metastasis
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
retinal vein occlusion
,
diabetes mellitus
,
hemophilia a
,
erectile dysfunction
,
hematologic diseases
,
hemostatic disorders
,
blood coagulation disorders
,
fatigue
,
healthy volunteers/patients
,
metabolism
,
breast neoplasms
,
circulating neoplastic cells
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use